Is Jiangxi Rimag Group (HKG:2522) Using Too Much Debt?
Is Jiangxi Rimag Group (HKG:2522) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. As with many other companies Jiangxi Rimag Group Co., Ltd. (HKG:2522) makes use of debt. But should shareholders be worried about its use of debt?
霍华德·马克斯用很好地表达了他对于股价波动的担忧,他说:“永久损失的可能性是我担心的风险...我认识的每个实践投资者都会担心这个。”因此,明智的资金知道,债务——通常涉及破产——是评估公司风险时非常重要的因素。正如许多其他公司一样,一脉阳光医学影像(临时代码)也使用债务。但股东们应该担心公司使用债务吗?
When Is Debt A Problem?
什么时候负债才是一个问题?
Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first step when considering a company's debt levels is to consider its cash and debt together.
债务能够帮助企业,直到企业无法用新资本或自由现金流支付债务。在最糟糕的情况下,如果企业无法偿还债权人,它可以破产。然而,更常见的(但仍然痛苦的)情况是,它必须以低价筹集新的股本资金,从而永久性地稀释股东的所有权。话虽如此,最常见的情况是一家公司合理地管理其债务-并且出于自身利益。考虑公司的债务水平时的第一步是将其现金和债务一起考虑。
What Is Jiangxi Rimag Group's Debt?
一脉阳光医学影像(临时代码)的债务是什么?
The image below, which you can click on for greater detail, shows that Jiangxi Rimag Group had debt of CN¥265.4m at the end of June 2024, a reduction from CN¥358.2m over a year. However, it does have CN¥322.5m in cash offsetting this, leading to net cash of CN¥57.2m.
下面的图片显示,您可以点击查看更详细信息,显示一脉阳光医学影像(临时代码)于2024年6月底的债务为人民币26540万,较一年前的人民币35820万有所减少。然而,它有人民币32250万的现金来抵消这部分债务,导致净现金为人民币5720万。

How Healthy Is Jiangxi Rimag Group's Balance Sheet?
一脉阳光医学影像(临时代码)的资产负债表表现如何?
We can see from the most recent balance sheet that Jiangxi Rimag Group had liabilities of CN¥373.5m falling due within a year, and liabilities of CN¥242.4m due beyond that. Offsetting these obligations, it had cash of CN¥322.5m as well as receivables valued at CN¥436.7m due within 12 months. So it can boast CN¥143.3m more liquid assets than total liabilities.
我们可以从最近的资产负债表看出,一脉阳光医学影像(临时代码)有一笔当年到期的负债为人民币37350万,以及一笔到期超过一年的负债为人民币24240万。 抵消这些义务的是,它拥有人民币32250万的现金,以及价值人民币43670万的应收账款,需在12个月内到期。因此,它拥有比总负债多人民币14330万的流动资产。
This state of affairs indicates that Jiangxi Rimag Group's balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So while it's hard to imagine that the CN¥17.2b company is struggling for cash, we still think it's worth monitoring its balance sheet. Simply put, the fact that Jiangxi Rimag Group has more cash than debt is arguably a good indication that it can manage its debt safely.
事实表明,一脉阳光医学影像(临时代码)的资产负债表看起来相当稳固,因为其总负债几乎等于其流动资产。 因此,虽然很难想象这家总资产为172亿人民币的公司会缺现金,但我们仍认为值得监控其资产负债表。 简而言之,一脉阳光医学影像(临时代码)持有的现金多于债务,可以说是一个良好的迹象,表明它可以安全地管理债务。
Shareholders should be aware that Jiangxi Rimag Group's EBIT was down 89% last year. If that decline continues then paying off debt will be harder than selling foie gras at a vegan convention. There's no doubt that we learn most about debt from the balance sheet. But it is future earnings, more than anything, that will determine Jiangxi Rimag Group's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.
股东应意识到,一脉阳光医学影像(临时代码)去年的税息前利润(EBIt)下降了89%。 如果这种下降持续下去,那偿还债务会比在纯素食者大会上出售鹅肝更困难。 毫无疑问,我们从资产负债表中获取的关于债务的信息最多。 但更重要的是,将决定一脉阳光医学影像(临时代码)未来业务能否保持健康资产负债表的是未来收入。 因此,如果您关注未来,可以查看这份免费关于分析师盈利预测的报告。
Finally, a company can only pay off debt with cold hard cash, not accounting profits. While Jiangxi Rimag Group has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. During the last two years, Jiangxi Rimag Group burned a lot of cash. While investors are no doubt expecting a reversal of that situation in due course, it clearly does mean its use of debt is more risky.
最后,一家公司只能用冰冷的现金偿还债务,而不是用会计利润。 尽管一脉阳光医学影像(临时代码)的资产负债表上有净现金,但仍然值得看一看它将息税前利润(EBIT)转化为自由现金流的能力,以帮助我们了解其建立(或侵蚀)现金余额的速度。 在过去两年中,一脉阳光医学影像(临时代码)烧掉了大量现金。 虽然投资者无疑希望该情况将很快逆转,但这显然意味着其使用债务更具风险。
Summing Up
总之
While we empathize with investors who find debt concerning, you should keep in mind that Jiangxi Rimag Group has net cash of CN¥57.2m, as well as more liquid assets than liabilities. Despite its cash we think that Jiangxi Rimag Group seems to struggle to grow its EBIT, so we are wary of the stock. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Case in point: We've spotted 2 warning signs for Jiangxi Rimag Group you should be aware of.
尽管我们对发现债务令人担忧的投资者表示同情,但您应该记住,一脉阳光医学影像(临时代码)的净现金为5720万人民币,流动资产多于负债。 尽管有现金,我们认为一脉阳光医学影像(临时代码)似乎在努力增长EBIt,所以我们对这支股票持谨慎态度。 在分析债务水平时,资产负债表是开多的地方。 但从长远来看,每家公司都可能存在超出资产负债表之外的风险。 一例为:我们发现了一脉阳光医学影像(临时代码)的2个警示信号,您应该注意。
When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.
当一切尘埃落定时,有时更容易专注于那些甚至不需要债务的公司。读者可以立即免费查看零净债务的成长股列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。